PATRYS Ltd (PAB) - Total Assets
Based on the latest financial reports, PATRYS Ltd (PAB) holds total assets worth AU$1.74 Million AUD (≈ $1.23 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See what is PATRYS Ltd's book value for net asset value and shareholders' equity analysis.
PATRYS Ltd - Total Assets Trend (2007–2025)
This chart illustrates how PATRYS Ltd's total assets have evolved over time, based on quarterly financial data.
PATRYS Ltd - Asset Composition Analysis
Current Asset Composition (June 2025)
PATRYS Ltd's total assets of AU$1.74 Million consist of 100.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 42.7% |
| Accounts Receivable | AU$825.28K | 47.5% |
| Inventory | AU$0.00 | 0.0% |
| Property, Plant & Equipment | AU$0.00 | 0.0% |
| Intangible Assets | AU$0.00 | 0.0% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (2007–2025)
This chart illustrates how PATRYS Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see PATRYS Ltd (PAB) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: PATRYS Ltd's current assets represent 100.0% of total assets in 2025, an increase from 92.4% in 2007.
- Cash Position: Cash and equivalents constituted 42.7% of total assets in 2025, down from 92.0% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 434.0% in 2007.
- Asset Diversification: The largest asset category is accounts receivable at 47.5% of total assets.
PATRYS Ltd Competitors by Total Assets
Key competitors of PATRYS Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
| No similar companies found. | ||
PATRYS Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.73 | 5.53 | 10.23 |
| Quick Ratio | 1.73 | 5.53 | 10.23 |
| Cash Ratio | 0.74 | 3.25 | 8.41 |
| Working Capital | AU$732.87K | AU$3.12 Million | AU$4.37 Million |
PATRYS Ltd - Advanced Valuation Insights
This section examines the relationship between PATRYS Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 13.02 |
| Latest Market Cap to Assets Ratio | 4.02 |
| Asset Growth Rate (YoY) | -58.2% |
| Total Assets | AU$1.74 Million |
| Market Capitalization | $6.99 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values PATRYS Ltd's assets at a significant premium (4.02x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: PATRYS Ltd's assets decreased by 58.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for PATRYS Ltd (2007–2025)
The table below shows the annual total assets of PATRYS Ltd from 2007 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$1.74 Million ≈ $1.23 Million |
-58.21% |
| 2024-06-30 | AU$4.16 Million ≈ $2.94 Million |
-44.69% |
| 2023-06-30 | AU$7.52 Million ≈ $5.32 Million |
-46.14% |
| 2022-06-30 | AU$13.97 Million ≈ $9.88 Million |
+8.36% |
| 2021-06-30 | AU$12.89 Million ≈ $9.12 Million |
+139.79% |
| 2020-06-30 | AU$5.38 Million ≈ $3.80 Million |
-32.23% |
| 2019-06-30 | AU$7.93 Million ≈ $5.61 Million |
-0.49% |
| 2018-06-30 | AU$7.97 Million ≈ $5.64 Million |
+152.43% |
| 2017-06-30 | AU$3.16 Million ≈ $2.23 Million |
-25.83% |
| 2016-06-30 | AU$4.26 Million ≈ $3.01 Million |
-10.77% |
| 2015-06-30 | AU$4.77 Million ≈ $3.38 Million |
-67.78% |
| 2014-06-30 | AU$14.81 Million ≈ $10.48 Million |
+24.97% |
| 2013-06-30 | AU$11.85 Million ≈ $8.39 Million |
-11.29% |
| 2012-06-30 | AU$13.36 Million ≈ $9.45 Million |
-10.00% |
| 2011-06-30 | AU$14.85 Million ≈ $10.50 Million |
-8.96% |
| 2010-06-30 | AU$16.31 Million ≈ $11.54 Million |
-14.97% |
| 2009-06-30 | AU$19.18 Million ≈ $13.57 Million |
-19.62% |
| 2008-06-30 | AU$23.86 Million ≈ $16.88 Million |
+2813.74% |
| 2007-06-30 | AU$818.81K ≈ $579.36K |
-- |
About PATRYS Ltd
Patrys Limited, together with its subsidiaries, develops antibody technologies for the treatment of cancer and NETosis-driven inflammatory diseases. It develops PAT-DX1, a small antibody fragment derived from a humanized version of the binding domain from the original mouse deoxymab antibody 3E10; and PAT-DX3 for treating primary and secondary brain cancers, and metastases that are associated wit… Read more